Foundation For Angelman Syndrome Therapeutics

EIN: 263160079

Accepts Applications

Total Assets

$58.4M

Key Financial Metrics (2024)

Total Giving

$5.6M

Number of Grants

Median Grant

$179K

Grant Range

$29K - $1.9M

Historical Giving Trends

Year	Assets	Total Giving	# Grants	Median Grant
2024	$58.4M	$5.6M	17	$179K
2023	$63.1M	$800K	4	$204K

Recent Grant Recipients

TEXAS A&M UNIVERSITY

FT2019-008: TRANSLATIONAL RESEARCH IN PIG MODEL OF AS

• 2023

$267K

DUKE UNIVERSITY

FT2018-005 AMENDED: GPIC-COMM

• 2023

$75K

YALE UNIVERSITY

FT2020-006: GENERATION AND CHARACTERIZATION OF A NEW AS MOUSE MODEL THAT RECAPITULATES THE LARGE DELETION OF HUMAN 15Q11-Q13 AND A CONTROL LINE THAT CARRIES A DELETION OF ALL GENES IN 15Q11-Q13 BUT UBE3A

• 2023

$257K

YALE UNIVERSITY

PD2022-001: POSTDOCTORAL FELLOWSHIP PROGRAM

• 2023

$51K

UNIVERSITY OF PENNSYLVANIA

UPENN 2023: RESEARCH, COLLABORATION & LICENSE AGREEMENT

• 2023

$1.9M

NORTH CAROLINA STATE UNIVERSITY

FT2021-002: ISOGENICALLY CONTROLLED HUMAN CELL LINES TARGETING ABERRANT IMPRINTING GENOTYPES AND A NEW REPORTER CELL LINE.

• 2023

$162K

NORTH CAROLINA STATE UNIVERSITY

FT2022-001: MICROPROBE-INTEGRATED HUMAN ORGANOID ARRAYS TO STUDY AS GENOTYPES AND THERAPEUTICS

• 2023

$179K

NORTH CAROLINA STATE UNIVERSITY

FT2022-008: STEM CELL LINE IN-VITRO INFRASTRUCTURE CREATED AT NCSU FOR INDUSTRY AND ACADEMIC SUPPORT

• 2023

$43K

NORTH CAROLINA STATE UNIVERSITY

RADAR 2023-2137

• 2023

$29K

KECK GRADUATE INSTITUTE OF APPLIED LIFE SCIENCES

FT2022-002: TARGETING ANGELMAN SYNDROME THERAPEUTICS TO THE BRAIN UTILIZING NOVEL CELL PENETRATING PEPTIDES

• 2023

$250K

Quick Facts

Location

Texas

Return Type

990

Most Recent Filing

2024

Annual Expenses

$23.2M

Giving Rate

9.5% of assets

Application Policy

Accepts Applications

Yes - Open to Applications